Exact Mass: 309.1277338

Exact Mass Matches: 309.1277338

Found 500 metabolites which its exact mass value is equals to given mass value 309.1277338, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-acetylneuraminate

(4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2, 3-trihydroxypropyl]oxane-2-carboxylic acid

C11H19NO9 (309.1059764)

Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID A018; [MS2] KO008824 KEIO_ID A018 N-Acetylneuraminic acid is a sialic acid monosaccharide ubiquitous on cell membrane glycoproteins and glycolipids of mammalian cell ganglioglycerides, which plays a biological role in neurotransmission, leukocyte vasodilation, and viral or bacterial infection.

Fluperlapine

6-fluoro-10-(4-methylpiperazin-1-yl)-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaene

C19H20FN3 (309.1641172)

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

9-O-Acetylneuraminic acid

O-Acetylneuraminic acid; O-Acetylated sialic acid

C11H19NO9 (309.10597640000003)

The acetate ester of the primary hydroxy group of neuraminic acid.

Isotan B

3H-isoindol-1-yl (3S,4S,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carboxylate

C14H15NO7 (309.08484799999997)

Fulvine

Isocromadurine

C16H23NO5 (309.1576148)

Lunamarine

C18H15NO4 (309.100103)

7-Deoxypancratistatin

C14H15NO7 (309.08484799999997)

SB 218655

4-(Fluorophenyl)-1-cyclopropylmethyl-5-(2-amino-4-pyrimidinyl)imidazole

C17H16FN5 (309.1389668)

Pellidole

Diacetylaminoazotoluene

C18H19N3O2 (309.14771939999997)

Butenachlor

N-[[(E)-but-2-enoxy]methyl]-2-chloro-N-(2,6-diethylphenyl)acetamide

C17H24ClNO2 (309.1495474)

ISOPROPALIN

C15H23N3O4 (309.1688478)

CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10647; ORIGINAL_PRECURSOR_SCAN_NO 10642 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10600; ORIGINAL_PRECURSOR_SCAN_NO 10598 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10624; ORIGINAL_PRECURSOR_SCAN_NO 10622 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10736; ORIGINAL_PRECURSOR_SCAN_NO 10734 CONFIDENCE standard compound; INTERNAL_ID 1344; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10608; ORIGINAL_PRECURSOR_SCAN_NO 10605

N-Glycolyl-Muramic Acid

N-Glycolylmuramic acid; 2-Glycolylamido-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose

C11H19NO9 (309.10597640000003)

N-Acetylneuraminic acid

(2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C11H19NO9 (309.1059764)

N-Acetylneuraminic acid (NeuAc) (CAS: 131-48-6), also known as sialic acid, is an acetyl derivative of the amino sugar neuraminic acid. It occurs in many glycoproteins, glycolipids, and polysaccharides in both mammals and bacteria. The most abundant sialic acid, NeuAc, is synthesized in vivo from N-acetylated D-mannosamine (ManNAc) or D-glucosamine (GlcNAc). NeuAc and its activated form, CMP-NeuAc, are biosynthesized in five consecutive reactions that form the intermediates UDP-N-acetylglucosamine (UDP-GlcNAc), N-acetylmannosamine (ManNAc), ManNAc 6-phosphate, NeuAc 9-phosphate, and CMP-NeuAc. CMP-NeuAc is transported into the Golgi apparatus and, with the aid of specific sialyltransferases, added onto nonreducing positions on oligosaccharide chains of glycoproteins and glycolipids. NeuAc is widely distributed throughout human tissues and found in several fluids, including serum, cerebrospinal fluid, saliva, urine, amniotic fluid, and breast milk. It is found in high levels in the brain, adrenal glands, and the heart. Serum and urine levels of the free acid are elevated in individuals suffering from renal failure. Serum and saliva Neu5Ac levels are also elevated in alcoholics. A genetic disorder known as Salla disease or infantile NeuAc storage disease is also characterized by high serum and urine levels of this compound. The negative charge is responsible for the slippery feel of saliva and mucins coating the bodys organs. This particular sialic acid is known to act as a "decoy"" for invading pathogens. Along with involvement in preventing infections (mucus associated with mucous membranes — mouth, nose, GI, respiratory tract), Neu5Ac acts as a receptor for influenza viruses, allowing attachment to mucous cells via hemagglutinin (an early step in acquiring influenzavirus infection). NeuAc is also becoming known as an agent necessary for mediating ganglioside distribution and structures in the brain. Sialic acid (SA) is an N-acetylated derivative of neuraminic acid that is an abundant terminal monosaccharide of glycoconjugates. Normal human serum SA is largely bound to glycoproteins or glycolipids (total sialic acid (TSA): 1.5-2.5 mmol/L), with small amounts of free SA (1-3 umol/L). Negatively charged SA units stabilize glycoprotein conformation in cell surface receptors to increase cell rigidity. This enables signal recognition and adhesion to ligands, antibodies, enzymes, and microbes. SA residues are antigenic determinant residues in carbohydrate chains of glycolipids and glycoproteins, chemical messengers in tissue and body fluids, and may regulate glomeruli basement membrane permeability. Sialic acids are structurally unique nine-carbon keto sugars occupying the interface between the host and commensal or pathogenic microorganisms. An important function of host sialic acid is to regulate innate immunity. Sialic acid is the moiety most actively recycled for metabolic purposes in the salvage pathways in glycosphingolipid metabolism. Sialic acid is indispensable for the neuritogenic activities of ganglioside constituents which are unique in that a sialic acid directly binds to the glucose of the cerebroside, they are mutually connected in tandem, and some are located in the internal parts of the sugar chain. Sialylation (sialic acid linked to galactose, N-acetylgalactosamine, or another sialic acid) represents one of the most frequently occurring terminations of the oligosaccharide chains of glycoproteins and glycolipids. The biosynthesis of the various linkages is mediated by the different members of the sialyltransferase family (PMID: 11425186, 11287396, 12770781, 16624269, 12510390, 15007099). N-Acetylneuraminic acid is a sialic acid monosaccharide ubiquitous on cell membrane glycoproteins and glycolipids of mammalian cell ganglioglycerides, which plays a biological role in neurotransmission, leukocyte vasodilation, and viral or bacterial infection.

N-Acetyl-a-neuraminic acid

(2R,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C11H19NO9 (309.10597640000003)

N-Acetyl-alpha-neuraminate is a sialic acid. Sialic acids are an important family of related 9-carbon sugars acids, present on the surface of many different cells and functioning in a wide range of different biological processes. They mediate a variety of cell-cell and cell-molecule interactions in eukaryotes and can be utilized by pathogens to evade the host immune response. N-acetylneuraminic acid is the most common sialic acid, and the predominant form present in humans. It can be found as a terminal sugar on a wide range of surface glycoconjugates. A number of bacteria that can colonize humans (such as E. coli) make use of N-acetylneuraminic acid as a nutrient source. N-Acetyl-a-neuraminic acid is a derivatized monosaccharide. Neuraminic acid derivatives are found widely distributed in animal tissues and in bacteria. The N- or O-substituted derivatives of neuraminic acid are collectively known as sialic acids, the predominant one being N-acetylneuraminic acid. [HMDB] N-Acetylneuraminic acid is a sialic acid monosaccharide ubiquitous on cell membrane glycoproteins and glycolipids of mammalian cell ganglioglycerides, which plays a biological role in neurotransmission, leukocyte vasodilation, and viral or bacterial infection.

Pro-Pro-Pro

C15H23N3O4 (309.1688478)

A tripeptide composed of three L-proline units joined by peptide linkages.

Evadol hydrochloride

C16H20ClNO3 (309.113164)

Ketotifen

2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),4,10,12-pentaen-8-one

C19H19NOS (309.1187284)

Ketotifen is only found in individuals that have used or taken this drug. It is a cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis. [PubChem]Ketotifen is a relatively selective, non-competitive histamine antagonist (H1-receptor) and mast cell stabilizer. Ketotifen inhibits the release of mediators from mast cells involved in hypersensitivity reactions. Decreased chemotaxis and activation of eosinophils have also been demonstrated. Ketotifen also inhibits cAMP phosphodiesterase. Properties of ketotifen which may contribute to its antiallergic activity and its ability to affect the underlying pathology of asthma include inhibition of the development of airway hyper-reactivity associated with activation of platelets by PAF (Platelet Activating Factor), inhibition of PAF-induced accumulation of eosinophils and platelets in the airways, suppression of the priming of eosinophils by human recombinant cytokines and antagonism of bronchoconstriction due to leukotrienes. Ketotifen inhibits of the release of allergic mediators such as histamine, leukotrienes C4 and D4(SRS-A) and PAF. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Fluoxetine

N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine

C17H18F3NO (309.1340414)

Fluoxetine hydrochloride is the first agent of the class of antidepressants known as selective serotonin-reuptake inhibitors (SSRIs). Despite distinct structural differences between compounds in this class, SSRIs possess similar pharmacological activity. As with other antidepressant agents, several weeks of therapy may be required before a clinical effect is seen. SSRIs are potent inhibitors of neuronal serotonin reuptake. They have little to no effect on norepinephrine or dopamine reuptake and do not antagonize α- or β-adrenergic, dopamine D₂ or histamine H₁ receptors. During acute use, SSRIs block serotonin reuptake and increase serotonin stimulation of somatodendritic 5-HT_1A and terminal autoreceptors. Chronic use leads to desensitization of somatodendritic 5-HT_1A and terminal autoreceptors. The overall clinical effect of increased mood and decreased anxiety is thought to be due to adaptive changes in neuronal function that lead to enhanced serotonergic neurotransmission. Side effects include dry mouth, nausea, dizziness, drowsiness, sexual dysfunction, and headache. Side effects generally occur within the first two weeks of therapy and are usually less severe and frequent than those observed with tricyclic antidepressants. Fluoxetine may be used to treat major depressive disorder (MDD), moderate to severe bulimia nervosa, obsessive-compulsive disorder (OCD), premenstrual dysphoric disorder (PMDD), panic disorder with or without agoraphobia, and, in combination with olanzapine, for treatment-resistant or bipolar I depression. Fluoxetine is the most anorexic and stimulating SSRI. D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065690 - Cytochrome P-450 CYP2D6 Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Cryptodorine

5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C18H15NO4 (309.100103)

Alkaloid from the leaves of Laurus nobilis (bay laurel). Cryptodorine is found in tea, sweet bay, and herbs and spices. Cryptodorine is found in herbs and spices. Cryptodorine is an alkaloid from the leaves of Laurus nobilis (bay laurel).

Koenigine

13-methoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11,13,15-heptaen-14-ol

C19H19NO3 (309.13648639999997)

Koenigine is found in herbs and spices. Koenigine is an alkaloid from the leaves of Murraya koenigii (curryleaf tree

Piperolactam C

13,14,15-trimethoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2,4,6,8,12(16),13-heptaen-11-one

C18H15NO4 (309.100103)

Piperolactam C is found in herbs and spices. Piperolactam C is an alkaloid from the whole plants of Piper longum (long pepper),. Alkaloid from the whole plants of Piper longum (long pepper),. Piperolactam C is found in herbs and spices.

Glutaminyltyrosine

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-(4-hydroxyphenyl)propanoate

C14H19N3O5 (309.1324644)

Glutaminyltyrosine is a dipeptide composed of glutamine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Lysyltyrosine

(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688478)

Lysyltyrosine is a dipeptide composed of lysine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Tyrosyl-Lysine

6-Amino-2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}hexanoate

C15H23N3O4 (309.1688478)

Tyrosyl-Lysine is a dipeptide composed of tyrosine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Tyrosyl-Glutamine

2-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-4-(C-hydroxycarbonimidoyl)butanoate

C14H19N3O5 (309.1324644)

Tyrosyl-Glutamine is a dipeptide composed of tyrosine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Metixene

1-Methyl-3-(thioxanthen-9-ylmethyl)- piperidine hydrochloride

C20H23NS (309.15511180000004)

Metixene is only found in individuals that have used or taken this drug. It is a anticholinergic used as an anti-parkinson drug. [Wikipedia]Parkinsonism is thought to result from an imbalance between the excitatory (cholinergic) and inhibitory (dopaminergic) systems in the corpus striatum. The mechanism of action of centrally active anticholinergic drugs such as metixene is considered to relate to competitive antagonism of acetylcholine at muscarinic receptors in the corpus striatum, which then restores the balance. N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

Tyrosyl-Gamma-glutamate

2-Amino-4-{[2-amino-3-(4-hydroxyphenyl)propanoyl]-C-hydroxycarbonimidoyl}butanoate

C14H19N3O5 (309.1324644)

Tyrosyl-Gamma-glutamate is a dipeptide composed of tyrosine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Sapanisertib

5-[4-amino-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine

C15H15N7O (309.133802)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Sapanisertib (INK-128; MLN0128; TAK-228) is an orally available, ATP-dependent mTOR1/2 inhibitor with an IC50 of 1 nM for mTOR kinase. Sapanisertib (INK-128; MLN0128; TAK-228) is an orally available, ATP-dependent mTOR1/2 inhibitor with an IC50 of 1 nM for mTOR kinase.

N-Benzyl-9-(tetrahydro-2H-pyran-2-YL)adenine

C17H19N5O (309.1589524)

BAP9THP is a synthetic cytokinin derivative and a growth regulator. BAP9THP promotes chlorophyll retention (and senescence delay) in plant tissues exceptionally strongly, and growth of tobacco callus almost as strongly as 6-Benzylaminopurine (BAP). BAP9THP induces adventitious shoot formation ignificantly more strongly than N6-isopentenyladenine or Kinetin[1][2].

3h-Sialic acid

2,4-Dihydroxy-5-[(1-hydroxyethylidene)amino]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylate

C11H19NO9 (309.10597640000003)

H-Arg(NO2)-Obzl

benzyl 2-amino-5-{[amino(nitroamino)methylidene]amino}pentanoate

C13H19N5O4 (309.1436974)

8-Hydroxyondansetron

8-hydroxy-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one

C18H19N3O2 (309.14771939999997)

N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide

N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulphonamide

C14H19N3O3S (309.11470640000005)

1,3-Dibenzylisoquinoline

Bis-benzyl-isoquinolines

C23H19N (309.15174140000005)

Diacetazotol

N-acetyl-N-{2-methyl-4-[2-(2-methylphenyl)diazen-1-yl]phenyl}acetamide

C18H19N3O2 (309.14771939999997)

Gevotroline

8-Fluoro-2,3,4,5-tetrahydro-2-[3-(3-pyridinyl)propyl]1H-pyrido[4,3-b]indole

C19H20FN3 (309.1641172)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Glucose-6-glutamate

4-amino-5-oxo-5-[(2,3,4,5-tetrahydroxy-6-oxohexyl)oxy]pentanoic acid

C11H19NO9 (309.10597640000003)

Tyrosyl-alanyl-glycine

2-{2-[2-amino-3-(4-hydroxyphenyl)propanamido]propanamido}acetic acid

C14H19N3O5 (309.1324644)

Nerisopam

1-(4-Aminophenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine monohydrochloride

C18H19N3O2 (309.14771939999997)

C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

9-O-Acetylneuraminic acid

6-[3-(acetyloxy)-1,2-dihydroxypropyl]-5-amino-2,4-dihydroxyoxane-2-carboxylic acid

C11H19NO9 (309.10597640000003)

Pro-Pro-Pro

1-[1-(pyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid

C15H23N3O4 (309.1688478)

Pyridone 6

4-tert-butyl-15-fluoro-3,5,10-triazatetracyclo[11.4.0.0²,⁶.0⁷,¹²]heptadeca-1,3,6,8,12,14,16-heptaen-11-one

C18H16FN3O (309.1277338)

Aceneuramic acid

4,6,7,8,9-Pentahydroxy-5-[(1-hydroxyethylidene)amino]-2-oxononanoate

C11H19NO9 (309.10597640000003)

vibunazole

1-(4-chlorophenoxy)-3,3-dimethyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butan-2-ol

C15H20ClN3O2 (309.124397)

D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

Zacopride

4-Amino-N-{1-azabicyclo[2.2.2]octan-3-yl}-5-chloro-2-methoxybenzene-1-carboximidate

C15H20ClN3O2 (309.124397)

(-)-Stephanine; (R)-(-)-Stephanine; 8-Methoxy-1,2-(methylenedioxy)-6abeta-aporphine; Stephanin; l-Stephanine

C19H19NO3 (309.13648639999997)

N-Demethylcrychine

(-)-N-Demethylcrychine

C18H15NO4 (309.100103)

MP 102

Demethylbialaphos

C10H20N3O6P (309.10896700000006)

N-Acetylneuraminic acid

N-Acetyl-alpha-neuraminic acid

C11H19NO9 (309.10597640000003)

An N-acylneuraminic acid where the N-acyl group is specified as acetyl. N-Acetylneuraminic acid with alpha configuration at the anomeric centre. N-Acetylneuraminic acid with beta configuration at the anomeric centre. MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; SQVRNKJHWKZAKO-PFQGKNLYSA-N_STSL_0228_N-Acetylneuraminic acid_2000fmol_190114_S2_LC02MS02_081; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. N-Acetylneuraminic acid is a sialic acid monosaccharide ubiquitous on cell membrane glycoproteins and glycolipids of mammalian cell ganglioglycerides, which plays a biological role in neurotransmission, leukocyte vasodilation, and viral or bacterial infection.

7-methoxyheptaphylline

C18H15NO4 (309.100103)

ZINC02558164

C12H15N5O5 (309.10731400000003)

Oriciacridone C

fluoxetine

C17H18F3NO (309.1340414)

D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065690 - Cytochrome P-450 CYP2D6 Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 8321 CONFIDENCE standard compound; EAWAG_UCHEM_ID 334 CONFIDENCE standard compound; INTERNAL_ID 1509

6-[1-(6,6-Dimethyl-3-oxo-bicyclo[3.1.0]hex-2-ylidene)-ethylamino]-chromen-2-one

"NCGC00160201-01!6-[1-(6,6-Dimethyl-3-oxo-bicyclo[3.1.0]hex-2-ylidene)-ethylamino]-chromen-2-one"

C19H19NO3 (309.13648639999997)

N-Acetylneuraminate

N-Acetylneuraminic acid

C11H19NO9 (309.10597640000003)

N-Acetylneuraminic acid is a sialic acid monosaccharide ubiquitous on cell membrane glycoproteins and glycolipids of mammalian cell ganglioglycerides, which plays a biological role in neurotransmission, leukocyte vasodilation, and viral or bacterial infection.

FLU_310.1415_14.5

C17H18F3NO (309.1340414)

C15H23N3O4 (309.1688478)

Fluoxetina

methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine

C17H18F3NO (309.1340414)

Tranylcypromine glucuronide

C15H19NO6 (309.1212314)

Sinapine

Sinapoylcholine

C16H23NO5 (309.1576148)

Hydroxyanastrozole

C17H19ON5 (309.1589524)

metixene

Methixen [German];Methixene;Methixene hydrochloride;Metisene [DCIT];Metixene hydrochloride;Metixeno [INN-Spanish];Metixenum [INN-Latin]

C20H23NS (309.15511180000004)

N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AA - Tertiary amines C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent

GLN-Tyr

2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-carbamoylbutanoic acid

C14H19N3O5 (309.1324644)

Lys-tyr

6-amino-2-[2-amino-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C15H23N3O4 (309.1688478)

A dipeptide formed from L-lysine and L-tyrosine residues.

Tyr-GLN

2-(2-amino-4-carbamoylbutanamido)-3-(4-hydroxyphenyl)propanoic acid

C14H19N3O5 (309.1324644)

A dipeptide formed from L-tyrosine and L-glutamine residues.

Tyr-lys

2-(2,6-diaminohexanamido)-3-(4-hydroxyphenyl)propanoic acid

C15H23N3O4 (309.1688478)

A dipeptide formed from L-tyrosine and L-lysine residues.

Tyr-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-(4-hydroxyphenyl)propanoic acid

C14H19N3O5 (309.1324644)

GGlu-Tyr

2-[2-amino-3-(4-hydroxyphenyl)propanamido]-4-(C-hydroxycarbonimidoyl)butanoic acid

C14H19N3O5 (309.1324644)

Kenigine

13-methoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaen-14-ol

C19H19NO3 (309.13648639999997)

Cryptodorine

5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0^{2,10}.0^{4,8}.0^{16,23}.0^{18,22}]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C18H15NO4 (309.100103)

piperolactam C

methyl 1-benzyl-2-ethyl-5-hydroxyindole-3-carboxylate

C19H19NO3 (309.13648639999997)

Betaine citrate

C11H19NO9 (309.10597640000003)

Sangivamycin

C12H15N5O5 (309.10731400000003)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers[1][2]. Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers[1][2].

4-(8-fluoro-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl)benzoic acid

C19H16FNO2 (309.1165008)

2-(3,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID

C18H15NO4 (309.100103)

(1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate

C18H15NO4 (309.100103)

3-(2-morpholin-4-ylethylamino)-6-phenylpyridazine-4-carbonitrile

C17H19N5O (309.1589524)

2-(BOC-AMINO)-6-FLUORO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-CARBOXYLIC ACID

C16H20FNO4 (309.1376292)

CZC8004

N2-(4-(Aminomethyl)phenyl)-5-fluoro-N4-phenylpyrimidine-2,4-diamine

C17H16FN5 (309.1389668)

s-Triazine, 2,4,6-triphenyl- (8CI)

C21H15N3 (309.126591)

sulfaguanole

C12H15N5O3S (309.089556)

C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

Citrulline malate

1-Cbz-2-Phenyl-4-oxopiperidine

C19H19NO3 (309.13648639999997)

1-[3-(Benzoyloxy)propyl]-2,3-dihydro-1H-indole-5-carboxaldehyde

C19H19NO3 (309.13648639999997)

BQCA

C18H15NO4 (309.100103)

BQCA a highly selective allosteric modulator of the M1 mAChR.

9-[(2-Acetoxyethoxy)methyl]-acetylguanine

C12H15N5O5 (309.10731400000003)

3-[methyl[4-[(4-nitrophenyl)azo]phenyl]amino]propiononitrile

C16H15N5O2 (309.122569)

4-chloro-7-triisopropylsilanyl-7H-pyrrolo[2,3-d]pyrimidine

C15H24ClN3Si (309.14279339999996)

N-(1-PHENYL-4,5-DIHYDRO-1 H-PYRAZOL-3-YL)-PHTHALAMIC ACID

C17H15N3O3 (309.11133600000005)

tert-Butyl [1-(2,5-difluorophenyl)-1-oxo-4-pentyn-2-yl]carbamate

C16H17F2NO3 (309.11764360000006)

3,5-dip-tolyl-4,5-dihydro-1h-pyrazole-1-carbothioamide

C18H19N3S (309.1299614)

4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID (2-AMINO-PHENYL)-AMIDE

C17H15N3O3 (309.11133600000005)

coumarin 153

C16H14F3NO2 (309.097658)

2-(4-Hydroxy-3-methoxy-phenyl)-quinoline-4-carboxylic acid methyl ester

C18H15NO4 (309.100103)

4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid methyl ester

C18H15NO4 (309.100103)

(3E)-2,3-Dihydro-3-(methoxyphenylmethylene)-2-oxo-1H-indole-6-carboxylic acid methyl ester

C18H15NO4 (309.100103)

(5-amino-2-butyl-1-benzofuran-3-yl)(4-hydroxyphenyl)methanone

C19H19NO3 (309.13648639999997)

N-Nitro-L-arginine benzyl ester

C13H19N5O4 (309.1436974)

Poly-L-proline

C15H23N3O4 (309.1688478)

Boc-Hse(Bzl)-OH

C16H23NO5 (309.1576148)

{[4-(2-Azido-3-methyl-5-oxotetrahydro-2-furanyl)phenyl]hydrazono}malononitrile

C14H11N7O2 (309.09741859999997)

Boc-Thr-OBzl

C16H23NO5 (309.1576148)

3,5,6-Triphenyl-1,2,4-triazine

C21H15N3 (309.126591)

BOC-3-AMINO-3-(BENZO[D][1,3]DIOXOL-5-YL)PROPANOICACID

C15H19NO6 (309.1212314)

2-Methyl-3,4,5-triphenyl-1H-pyrrole

C23H19N (309.15174140000005)

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-5-UREIDOPENTANOIC ACID

C14H19N3O5 (309.1324644)

1,2-Dithiolane-3-pentanamide, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]

C12H23NO4S2 (309.1068438)

4-(6-fluoro-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl)benzoic acid

C19H16FNO2 (309.1165008)

A 61603

C14H19N3O3S (309.11470640000005)

boc-s-tert-butylmercapto-l-cysteine

C12H23NO4S2 (309.1068438)

Boc-Thr(Bzl)-OH

C16H23NO5 (309.1576148)

2-Acetamido-4,6-O-benzylidene-2-deoxy-D-galactose

C15H19NO6 (309.1212314)

1-[3-(2-Methoxy-5-nitrophenoxy)propyl]-4-methylpiperazine

C15H23N3O4 (309.1688478)

1-[4-(Benzyloxy)-1H-indol-2-yl]ethyl acetate

C19H19NO3 (309.13648639999997)

(R)-beta-[[(tert-Butoxy)carbonyl]amino]-1,3-benzodioxole-5-propanoic acid

C15H19NO6 (309.1212314)

ethyl 6-(difluoromethoxy)-2,3,4,9-tetrahydro-1h-carbazole-1-carboxylate

C16H17F2NO3 (309.11764360000006)

1-[(3-aminopropyl)amino]-4-(methylamino)anthraquinone

C18H19N3O2 (309.14771939999997)

H-Gly-Phe-Ser-OH

C14H19N3O5 (309.1324644)

1,2-Diphenyl-1H-imidazo[1,2-a]benzimidazole

C21H15N3 (309.126591)

C23H19N (309.15174140000005)

Tyrosyl-Lysine

C15H23N3O4 (309.1688478)

N,O-Bis-(trimethylsilyl)phenylalanine

C15H27NO2Si2 (309.1580242)

Cyclohepta(b)pyrazolo(3,4-d)pyridin-3(2H)-one, 5,6,7,8,9,10-hexahydro-2-(4-methoxyphenyl)-

C18H19N3O2 (309.14771939999997)

1-[2-(2,5-Dimethylphenoxy)ethyl]-3-indolecarboxylic acid

C15H15N7O (309.133802)

L-Alanine,glycyl-L-tyrosyl-

C14H19N3O5 (309.1324644)

19-Methoxy-5,7-dioxa-13-azapentacyclo[11.7.0.01,16.02,10.04,8]icosa-2,4(8),9,11,15,17-hexaen-14-one

C18H15NO4 (309.100103)

Fructosyllysine(1+)

C12H25N2O7+ (309.16616799999997)

An amino-acid cation comprising fructosyllysine having a deprotonated carboxy group and both amino groups protonated; major species at pH 7.3.

Psicosyllysine(1+)

C12H25N2O7+ (309.16616799999997)

An amino-acid cation comprising psicosyllysine having a deprotonated carboxy group and both amino groups protonated; major species at pH 7.3.

Domoate

C15H19NO6-2 (309.1212314)

D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents

isodomoate A

C15H19NO6-2 (309.1212314)

Glucosyllysine

C12H25N2O7+ (309.16616799999997)

7-(3-Amino-5-hydroxyphenyl)-7-hydroxy-2,6-dimethyl-3,5-dioxoheptanoic acid

C15H19NO6 (309.1212314)

(4E)-4-[2-(2-carboxypyrrolidin-1-ium-1-ylidene)ethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylic acid

C14H17N2O6+ (309.10865620000004)

1-[(1E,3Z)-5-(2-carboxypyrrolidin-1-ium-1-ylidene)-4-hydroxypenta-1,3-dienyl]pyrrolidine-2-carboxylic acid

C15H21N2O5+ (309.1450396)

1-ethyl-6-methyl-3-[(E)-2-phenylethenyl]pyrimido[5,4-e][1,2,4]triazine-5,7-dione

C16H15N5O2 (309.122569)

Ala-Gly-Tyr

C14H19N3O5 (309.1324644)

A tripeptide composed of L-alanine, glycine, and L-tyrosine joined in sequence by peptide linkages.

2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetic acid

C14H19N3O5 (309.1324644)

N-[[6-cyano-5-(ethylamino)-3-methyl-2-pyrazinyl]methyl]-N-phenylacetamide

C17H19N5O (309.1589524)

N-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)methylene]-1H-indole-3-carbohydrazide

C17H19N5O (309.1589524)

3-[[2-Benzofuranyl(oxo)methyl]amino]benzoic acid ethyl ester

C18H15NO4 (309.100103)

2-(4-Acetyl-1-piperazinyl)-6-amino-4-(cyanomethyl)pyridine-3,5-dicarbonitrile

C15H15N7O (309.133802)

2-(5-Amino-1-phenyl-1,2,4-triazol-3-yl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione

C16H15N5O2 (309.122569)

2-(4-Fluorophenyl)-5-(4-methoxyanilino)-4-oxazolecarbonitrile

C17H12FN3O2 (309.0913504)

2-(2-Fluorophenyl)-5-(4-methoxyanilino)-4-oxazolecarbonitrile

C17H12FN3O2 (309.0913504)

1-[(2-Ethyl-4-hydroxy-4-methyl-1-oxopentyl)amino]-3-phenylthiourea

C15H23N3O2S (309.1510898)

2-(5,7-Dimethyl-3-phenyl-6-pyrazolo[1,5-a]pyrimidinyl)acetic acid ethyl ester

C18H19N3O2 (309.14771939999997)

methyl (5E)-5-(furan-2-ylmethylidene)-2-methyl-4-oxo-1-phenyl-4,5-dihydro-1H-pyrrole-3-carboxylate

C18H15NO4 (309.100103)

Ala-Tyr-Gly

C14H19N3O5 (309.1324644)

4-Phenyl-2,2:6,3-terpyridine

C21H15N3 (309.126591)

N-(1H-benzimidazol-2-yl)-4-(3-methylphenoxy)butanamide

C18H19N3O2 (309.14771939999997)

(5E)-5-[(1-ethyl-2,5-dimethylpyrrol-3-yl)methylidene]-3-phenylimidazolidine-2,4-dione

C18H19N3O2 (309.14771939999997)

2-chloro-N-[2-(2,2-dimethyl-4-phenyl-4-oxanyl)ethyl]acetamide

C17H24ClNO2 (309.1495474)

1-(4-phenylmethoxyphenyl)-N-(thiophen-2-ylmethyl)methanamine

C19H19NOS (309.1187284)

2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-(1-phenylethyl)acetamide

C18H19N3O2 (309.14771939999997)

1-Butyl-3-[(2-hydroxyphenyl)hydrazinylidene]-2-indolone

C18H19N3O2 (309.14771939999997)

3-methyl-N-[(4-methylphenyl)methyl]-7,8-dihydro-6H-cyclopenta[4,5]thieno[1,2-c]pyrimidin-1-amine

C18H19N3S (309.1299614)

1-[5-hydroxy-3-methyl-5-(3-pyridinyl)-4H-pyrazol-1-yl]-2-(4-methylphenyl)ethanone

C18H19N3O2 (309.14771939999997)

N-[[1H-indol-2-yl(oxo)methyl]amino]carbamic acid (phenylmethyl) ester

C17H15N3O3 (309.11133600000005)

2-amino-N-(2,3,4,5-tetrahydro-2,5-dioxo-1h-1-benzazepin-3-yl)benzamide

C17H15N3O3 (309.11133600000005)

5-Fluoro-2-[(3S)-1-(2-methylbenzyl)-3-pyrrolidinyl]-1H-benzimidazole

C19H20FN3 (309.1641172)

His-Pro-Gly

C13H19N5O4 (309.1436974)

Gly-Pro-His

C13H19N5O4 (309.1436974)

Tyr-Gly-Ala

C14H19N3O5 (309.1324644)

Phe-Gly-Ser

C14H19N3O5 (309.1324644)

Thr-Ser-Cys

C10H19N3O6S (309.0994514)

3-(5-Benzyloxyindol-3-yl)pyruvic acid

C18H15NO4 (309.100103)

1-[9-Ethyl-6-(1-hydroxyiminoethyl)-3-carbazolyl]ethanone oxime

C18H19N3O2 (309.14771939999997)

(S)-3-((6-(methoxymethyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino)-2,3-dihydrothiophene 1,1-dioxide

C12H15N5O3S (309.089556)

6-[[(2-Isopropoxyphenyloxy)carbonyl]amino]hexanoic acid

C16H23NO5 (309.1576148)

2-[(2R,3R,6S)-3-[(2-fluorobenzoyl)amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

2-[(2R,3R,6R)-3-[(2-fluorobenzoyl)amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

2-[(2R,3S,6R)-3-[[(2-fluorophenyl)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

1-[(1R,2aR,8bR)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone

C18H19N3O2 (309.14771939999997)

[(1S,2aR,8bR)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(3-pyridinyl)methanone

C18H19N3O2 (309.14771939999997)

5-tert-butyl-2-methyl-N-quinoxalin-6-ylpyrazole-3-carboxamide

C17H19N5O (309.1589524)

2-[(2S,3R,6R)-3-[[(2-fluorophenyl)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

2-[(2R,3S,6S)-3-[[(2-fluorophenyl)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

2-[(2S,3S,6R)-3-[[(2-fluorophenyl)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

2-[(2S,3S,6S)-3-[[(2-fluorophenyl)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]acetic acid

C15H16FNO5 (309.10124579999996)

1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone

C18H19N3O2 (309.14771939999997)

1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone

C18H19N3O2 (309.14771939999997)

1-[(1S,2aS,8bS)-1-(hydroxymethyl)-2a,3,4,8b-tetrahydro-1H-azeto[2,3-c]quinolin-2-yl]-2-(2-pyridinyl)ethanone

C18H19N3O2 (309.14771939999997)

[(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(3-pyridinyl)methanone

C18H19N3O2 (309.14771939999997)

Methyl 5-[(2-ethoxycarbonyl-3-oxohex-1-enyl)amino]uran-2-carboxylate

C15H19NO6 (309.1212314)

(Z)-4-glutaramidostilbene

C19H19NO3 (309.13648639999997)

C18H19N3O2 (309.14771939999997)

N-[[(E)-but-2-enoxy]methyl]-2-chloro-N-(2,6-diethylphenyl)acetamide

C17H24ClNO2 (309.1495474)

Pyridone 6

C18H16FN3O (309.1277338)

domoate(2-)

C15H19NO6 (309.1212314)

A tricarboxylic acid anion that is the conjugate base of domoic acid, arising from the deprotonation of the carboxy groups and protonation of the pyrrolidine nitrogen. Major species at pH 7.3.

Gevotroline

C19H20FN3 (309.1641172)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

Koenigine

C19H19NO3 (309.13648639999997)

N-[5-(4,5-Dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide

C14H19N3O3S (309.11470640000005)

Tyrosyl-Gamma-glutamate

C14H19N3O5 (309.1324644)

terreazepine

C17H15N3O3 (309.11133600000005)

A member of the class of benzazepines that is 2,3,4,5-tetrahydro-1H-1-benzazepine substituted by oxo groups at positions 2 and 5 and a o-aminobenzamido group at position 4. It is a secondary metabolite found in Aspergillus terreus.

gamma-Glu-Tyr(1-)

C14H17N2O6 (309.10865620000004)

A peptide anion obtained by deprotonation of both carboxy groups and protonation of the glutamyl amino group of gamma-Glu-Tyr. Major species at pH 7.3.

2-hydroxy-3-butenyldesulfoglucosinolate

C11H19NO7S (309.0882184)

A desulfoglucosinolic acid resulting from the formal condensation of the thiol group of (3S)-N,3-dihydroxypent-4-enethioamide with beta-D-glucopyranose.

Aceneuramate

C11H19NO9 (309.10597640000003)

NA-DOPA 7:0

C16H23NO5 (309.1576148)

Gly-Ala-Tyr

C14H19N3O5 (309.1324644)

Gly-Ser-Phe

C14H19N3O5 (309.1324644)

Pro-His-Gly

C13H19N5O4 (309.1436974)

Tyr-Ala-Gly

C14H19N3O5 (309.1324644)

7ACC2

C18H15NO4 (309.100103)

7ACC2 is a potent monocarboxylate transporter (MCT) inhibitor with an IC50 of 11 nM for inhibition of [14C]-lactate influx. 7ACC2 is also a potent inhibitor of mitochondrial pyruvate transport. 7ACC2 is an anticancer agent through inhibition of lactate flux[1][2].

A2A receptor antagonist 1

C16H12FN5O (309.1025834)

A2A receptor antagonist 1 (CPI-444 analog) is an antagonist of both adenosine A2A receptor and A1 receptor with Ki values of 4 and 264 nM, respectively[1].

CCT129957

C17H15N3O3 (309.11133600000005)

CCT129957 is an indole derivative and a potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of ~3 μM and a GC50 of 15 μM. CCT129957 inhibits Ca2+ release in squamous carcinoma cells at ~15 μM[1][2].

ZINC69391

C14H14F3N5 (309.12012400000003)

ZINC69391, a specific Rac1 inhibitor, interferes with Rac1-GEF interaction by masking Trp56 residue on Rac1 surface. ZINC69391 interferes with the interaction of Rac1 with Dock180 and reduces Rac1-GTP levels. ZINC69391 induces apoptosis, and shows antiproliferative and antimetastatic effects[1][2][3].